241 related articles for article (PubMed ID: 22839416)
1. Plasmodium vivax malaria relapses at a travel medicine centre in Rio de Janeiro, a non-endemic area in Brazil.
Pedro RS; Guaraldo L; Campos DP; Costa AP; Daniel-Ribeiro CT; Brasil P
Malar J; 2012 Jul; 11():245. PubMed ID: 22839416
[TBL] [Abstract][Full Text] [Related]
2. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
Brito M; Rufatto R; Brito-Sousa JD; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Batista Pereira D; Lacerda M
Lancet Infect Dis; 2024 Jun; 24(6):629-638. PubMed ID: 38452779
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Plasmodium vivax malaria recurrence in Brazil.
Daher A; Silva JCAL; Stevens A; Marchesini P; Fontes CJ; Ter Kuile FO; Lalloo DG
Malar J; 2019 Jan; 18(1):18. PubMed ID: 30670020
[TBL] [Abstract][Full Text] [Related]
4. Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.
Shimizu S; Kikuchi T; Koga M; Kato Y; Matsuoka H; Maruyama H; Kimura M;
Travel Med Infect Dis; 2015; 13(3):235-40. PubMed ID: 25482427
[TBL] [Abstract][Full Text] [Related]
5. Management of relapsing Plasmodium vivax malaria.
Chu CS; White NJ
Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.
Malla P; Wang Z; Brashear A; Yang Z; Lo E; Baird K; Wang C; Cui L
J Infect Dis; 2024 May; 229(5):1557-1564. PubMed ID: 38041857
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.
Pham TV; Nguyen HV; Aguirre AR; Nguyen VV; A Cleves M; Nguyen XX; Nguyen TT; Tran DT; Le HX; Hens N; Rosanas-Urgell A; D'Alessandro U; Speybroeck N; Erhart A
PLoS Med; 2019 May; 16(5):e1002784. PubMed ID: 31100064
[TBL] [Abstract][Full Text] [Related]
8. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
9. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria.
Duarte EC; Pang LW; Ribeiro LC; Fontes CJ
Am J Trop Med Hyg; 2001 Nov; 65(5):471-6. PubMed ID: 11716100
[TBL] [Abstract][Full Text] [Related]
10. Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.
Taylor WR; Hoglund RM; Peerawaranun P; Nguyen TN; Hien TT; Tarantola A; von Seidlein L; Tripura R; Peto TJ; Dondorp AM; Landier J; H Nosten F; Smithuis F; Phommasone K; Mayxay M; Kheang ST; Say C; Neeraj K; Rithea L; Dysoley L; Kheng S; Muth S; Roca-Feltrer A; Debackere M; Fairhurst RM; Song N; Buchy P; Menard D; White NJ; Tarning J; Mukaka M
Malar J; 2021 Sep; 20(1):366. PubMed ID: 34503519
[TBL] [Abstract][Full Text] [Related]
11. Efficacy in the treatment of malaria by Plasmodium vivax in Oiapoque, Brazil, on the border with French Guiana: the importance of control over external factors.
Gomes Mdo S; Vieira JL; Machado RL; Nacher M; Stefani A; Musset L; Legrand E; Menezes RA; Júnior AA; Sousa AP; Couto VS; Couto ÁA
Malar J; 2015 Oct; 14():402. PubMed ID: 26453152
[TBL] [Abstract][Full Text] [Related]
12. Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison.
Valdes A; Epelboin L; Mosnier E; Walter G; Vesin G; Abboud P; Melzani A; Blanchet D; Blaise N; Nacher M; Demar M; Djossou F
Malar J; 2018 Jun; 17(1):237. PubMed ID: 29921273
[TBL] [Abstract][Full Text] [Related]
13. Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
Nekkab N; Lana R; Lacerda M; Obadia T; Siqueira A; Monteiro W; Villela D; Mueller I; White M
PLoS Med; 2021 Apr; 18(4):e1003535. PubMed ID: 33891582
[TBL] [Abstract][Full Text] [Related]
14. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.
Martin Ramírez A; Lombardia González C; Soler Maniega T; Gutierrez Liarte Á; Domingo García D; Lanza Suárez M; Bernal Fernández MJ; Rubio JM
Malar J; 2020 Jul; 19(1):259. PubMed ID: 32680522
[TBL] [Abstract][Full Text] [Related]
15. Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study.
Townell N; Looke D; McDougall D; McCarthy JS
Malar J; 2012 Jun; 11():214. PubMed ID: 22727113
[TBL] [Abstract][Full Text] [Related]
16. Higher-Dose Primaquine to Prevent Relapse of
Chamma-Siqueira NN; Negreiros SC; Ballard SB; Farias S; Silva SP; Chenet SM; Santos EJM; Pereira de Sena LW; Póvoa da Costa F; Cardoso-Mello AGN; Marchesini PB; Peterka CRL; Viana GMR; Macedo de Oliveira A
N Engl J Med; 2022 Mar; 386(13):1244-1253. PubMed ID: 35353962
[TBL] [Abstract][Full Text] [Related]
17. Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.
Betuela I; Rosanas-Urgell A; Kiniboro B; Stanisic DI; Samol L; de Lazzari E; Del Portillo HA; Siba P; Alonso PL; Bassat Q; Mueller I
J Infect Dis; 2012 Dec; 206(11):1771-80. PubMed ID: 22966124
[TBL] [Abstract][Full Text] [Related]
18. Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.
Silvino ACR; Kano FS; Costa MA; Fontes CJF; Soares IS; de Brito CFA; Carvalho LH; Sousa TN
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122891
[No Abstract] [Full Text] [Related]
19. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy.
Goller JL; Jolley D; Ringwald P; Biggs BA
Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026
[TBL] [Abstract][Full Text] [Related]
20. Primaquine administration after falciparum malaria treatment in malaria hypoendemic areas with high incidence of falciparum and vivax mixed infection: pros and cons.
Wilairatana P; Tangpukdee N; Kano S; Krudsood S
Korean J Parasitol; 2010 Jun; 48(2):175-7. PubMed ID: 20585537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
